Shantini D. Gamage

Dr. Shantini D. Gamage


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2023 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
MMMichelle A. Moffa
Michelle A. Moffa
CRClare Rock
Clare Rock
Panagis GaliatsatosPanagis Galiatsatos
Panagis Galiatsatos
SGShantini D. Gamage
Shantini D. Gamage
KSKellogg Schwab
Kellogg Schwab
NENatalie G Exum
Natalie G Exum
Over the past two decades, the incidence of legionellosis has been steadily increasing in the United States though there is noclear explanation for the main factors driving the increase. While legionellosis is the leading cause of waterborne outbreaks in the US, most cases are sporadic and acquired in community settings where the environmental source is never identified. This scoping review aimed to summarise the drivers of infections in the USA and determine the magnitude of impact each potential driver may have. A total of 1,738 titles were screened, and 18 articles were identified that met the inclusion criteria. Strong evidence was found for precipitation as a major driver, and both temperature and relative humidity were found to be moderate drivers of incidence. Increased testing and improved diagnostic methods were classified as moderate drivers, and the ageing U.S. population was a minor driver of increasing incidence. Racial and socioeconomic inequities and water and housing infrastructure were found to be potential factors explaining the increasing incidence though they were largely understudied in the context of non-outbreak cases. Understanding the complex relationships between environmental, infrastructure, and population factors driving legionellosis incidence is important to optimise mitigation strategies and public policy.

5 April 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
MEMartin E. Evans
Martin E. Evans
LSLoretta A. Simbartl
Loretta A. Simbartl
SKStephen M. Kralovic
Stephen M. Kralovic
MCMarla Clifton
Marla Clifton
KDKathleen DeRoos
Kathleen DeRoos
GRGary A. Roselle
Gary A. Roselle
Objective: To assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on healthcare-associated infections (HAIs) reported from 128 acute-care and 132 long-term care Veterans Affairs (VA) facilities.Methods: We compared central-line–associated bloodstream infections (CLABSIs), ventilator-associated events (VAEs), catheter-associated urinary tract infections (CAUTIs), methicillin-resistant Staphylococcus aureus (MRSA), and Clostridioides difficile infections and rates reported from each facility monthly to a centralized database before the pandemic (February 2019 through January 2020) and during the pandemic (July 2020 through June 2021).Results: Nationwide VA COVID-19 admissions peaked in January 2021. Significant increases in the rates of CLABSIs, VAEs, and MRSA all-site HAIs (but not MRSA CLABSIs) were observed during the pandemic in acute-care facilities. There was no significant change in CAUTI rates, and C. difficile rates significantly decreased. There were no significant increases in HAIs in long-term care facilities.Conclusions: The COVID-19 pandemic had a differential impact on HAIs of various types in VA acute care, with many rates increasing. The decrease in CDI HAIs may be due, in part, to evolving diagnostic testing. The minimal impact of COVID-19 in VA long-term facilities may reflect differences in patient numbers and acuity and early recognition of the impact of the pandemic on nursing home residents leading to increased vigilance and optimization of infection prevention and control practices in that setting. These data support the need for building and sustaining conventional infection prevention and control strategies before and during a pandemic.

1 September 2016 in Infectious Disease Clinics of North America
Verified
Journal Article
Closed access
SGShantini D. Gamage
Shantini D. Gamage
MAMeredith Ambrose
Meredith Ambrose
SKStephen M. Kralovic
Stephen M. Kralovic
GRGary A. Roselle
Gary A. Roselle

24 March 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
KPKelly S Peterson
Kelly S Peterson
JLJulia Lewis
Julia Lewis
OPOlga V Patterson
Olga V Patterson
ACAlec B Chapman
Alec B Chapman
DDDaniel W Denhalter
Daniel W Denhalter
MJMakoto Jones
Makoto Jones
Background: Patient travel history can be crucial in evaluating evolving infectious disease events. Such information can be challenging to acquire in electronic health records, as it is often available only in unstructured text.Objective: This study aims to assess the feasibility of annotating and automatically extracting travel history mentions from unstructured clinical documents in the Department of Veterans Affairs across disparate health care facilities and among millions of patients. Information about travel exposure augments existing surveillance applications for increased preparedness in responding quickly to public health threats.Methods: Clinical documents related to arboviral disease were annotated following selection using a semiautomated bootstrapping process. Using annotated instances as training data, models were developed to extract from unstructured clinical text any mention of affirmed travel locations outside of the continental United States. Automated text processing models were evaluated, involving machine learning and neural language models for extraction accuracy.Results: Among 4584 annotated instances, 2659 (58%) contained an affirmed mention of travel history, while 347 (7.6%) were negated. Interannotator agreement resulted in a document-level Cohen kappa of 0.776. Automated text processing accuracy (F1 85.6, 95% CI 82.5-87.9) and computational burden were acceptable such that the system can provide a rapid screen for public health events.Conclusions: Automated extraction of patient travel history from clinical documents is feasible for enhanced passive surveillance public health systems. Without such a system, it would usually be necessary to manually review charts to identify recent travel or lack of travel, use an electronic health record that enforces travel history documentation, or ignore this potential source of information altogether. The development of this tool was initially motivated by emergent arboviral diseases. More recently, this system was used in the early phases of response to COVID-19 in the United States, although its utility was limited to a relatively brief window due to the rapid domestic spread of the virus. Such systems may aid future efforts to prevent and contain the spread of infectious diseases.

4 January 2024 in American Journal of Infection Control
Verified
Journal Article
Closed access
SGShantini D. Gamage
Shantini D. Gamage
CJChetan Jinadatha
Chetan Jinadatha
JRJr. Vincent Rizzo
Jr. Vincent Rizzo
PCPiyali Chatterjee
Piyali Chatterjee
HCHosoon Choi
Hosoon Choi
GRGary A. Roselle
Gary A. Roselle

5 August 2022 in Environmental Science & Technology
Verified
Journal Article
Closed access
SGShantini D. Gamage
Shantini D. Gamage
CJChetan Jinadatha
Chetan Jinadatha
JCJohn D. Coppin
John D. Coppin
SKStephen M. Kralovic
Stephen M. Kralovic
ABAlan Bender
Alan Bender
GRGary A. Roselle
Gary A. Roselle